21.590.42% ( -0.09 )
Delay Closed: Nov 17, 15:00:00Valuation
Current ValuationThe current P/E ratio is 18.16, below the reasonable range, cheaper than 86.15% of the time in the past 1 years, and the industry ranks 34/222, the industry Median 22.19.
18.16xP/E
¥21.68Stock price
¥1.19Earnings per share
18.16xP/E
Stock price¥21.68Earnings per share¥1.19
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 20.59x
- Typical range
- 18.49x–21.90x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.19x
015304560
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.19x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
000538SZYunnan Baiyao | 19.19x | 6.77% | ¥99.78B |
600196SHFOSUN PHARMA | 16.97x | 7.35% | ¥59.63B |
000999SZCR Sanjiu | 13.50x | 3.13% | ¥43.54B |
688578SHAllist | 12.63x | 31.69% | ¥36.70B |
000423SZDEEJ | 18.45x | 9.19% | ¥33.10B |
600079SHHWHG | 12.77x | 28.07% | ¥32.95B |
600566SHJUMPCAN | 15.68x | -- | ¥28.48B |
000513SZLIVZON GROUP | 18.23x | 17.70% | ¥28.40B |
002603SZYILING PHARMACEUTICAL | 18.68x | 14.94% | ¥25.81B |
600535SHTASLY | 17.58x | 17.08% | ¥21.50B |
000623SZJI LIN AO DONG | 6.70x | -- | ¥20.04B |
600380SHJoincare | 16.89x | 15.07% | ¥19.10B |
600062SHCR Double-Crane | 10.24x | 2.02% | ¥15.95B |
600267SHHISUN | 12.36x | 82.61% | ¥15.14B |
600750SHCRJZ | 17.63x | 3.92% | ¥14.82B |
600285SHLingrui Pharma | 16.06x | 9.20% | ¥13.29B |
600664SHHPGC | 19.93x | 71.43% | ¥12.62B |
605507SHGuobang Pharma | 19.50x | 12.03% | ¥12.13B |
300573SZXingqi Pharmaceutical | 14.78x | -- | ¥11.85B |
600993SHMYL | 18.29x | 14.44% | ¥10.88B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
